-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Regen BioPharma Inc annual/quarterly Nonoperating Income (Expense) history and growth rate from Q4 2022 to Q4 2023.
- Regen BioPharma Inc Nonoperating Income (Expense) for the quarter ending December 31, 2023 was -$227K, a 111% decline year-over-year.
- Regen BioPharma Inc annual Nonoperating Income (Expense) for 2024 was -$449K, a 124% decline from 2023.
- Regen BioPharma Inc annual Nonoperating Income (Expense) for 2023 was $1.84M, a 33.8% decline from 2022.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)